Clinical Trial Update: AD816 Crossover Study [Phase 2]

View source ↗

Summary

A Phase 2 crossover study for AD816 in obstructive sleep apnea has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• AD816

Snippet

Sponsor: Apnimed | Conditions: OSA, Obstructive Sleep Apnea | Phase 2 | Status: COMPLETED